| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laboratory for Immunological Research Schering-Plough Research Institute, Dardilly, France
TLRs function as molecular sensors to detect pathogen-derived products and trigger protective responses ranging from secretion of cytokines that increase the resistance of infected cells and chemokines that recruit immune cells to cell death that limits microbe spreading. Viral dsRNA participate in virus-infected cell apoptosis, but the signaling pathway involved remains unclear. In this study we show that synthetic dsRNA induces apoptosis of human breast cancer cells in a TLR3-dependent manner, which involves the molecular adaptor Toll/IL-1R domain-containing adapter inducing IFN-
and type I IFN autocrine signaling, but occurs independently of the dsRNA-activated kinase. Moreover, detailed molecular analysis of dsRNA-induced cell death established the proapoptotic role of IL-1R-associated kinase-4 and NF-
B downstream of TLR3 as well as the activation of the extrinsic caspases. The direct proapoptotic activity of endogenous human TLR3 expressed by cancerous cells reveals a novel aspect of the multiple-faced TLR biology, which may open new clinical prospects for using TLR3 agonists as cytotoxic agents in selected cancers.
This article has been cited by other articles:
|
|
 |
|
  H. Shojaei, H.-H. Oberg, M. Juricke, L. Marischen, M. Kunz, C. Mundhenke, F. Gieseler, D. Kabelitz, and D. Wesch Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human {gamma}{delta} T Cells Cancer Res., November 15, 2009; 69(22): 8710 - 8717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. J. O'Neill, C. E. Bryant, and S. L. Doyle Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer Pharmacol. Rev., June 1, 2009; 61(2): 177 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Cho, R. J. C. Albuquerque, M. E. Kleinman, V. Tarallo, A. Greco, M. Nozaki, M. G. Green, J. Z. Baffi, B. K. Ambati, M. De Falco, et al. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth PNAS, April 28, 2009; 106(17): 7137 - 7142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chiron, C. Pellat-Deceunynck, M. Amiot, R. Bataille, and G. Jego TLR3 Ligand Induces NF-{kappa}B Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-{alpha} Production J. Immunol., April 1, 2009; 182(7): 4471 - 4478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Scharer, C. D. McCabe, M. Ali-Seyed, M. F. Berger, M. L. Bulyk, and C. S. Moreno Genome-Wide Promoter Analysis of the SOX4 Transcriptional Network in Prostate Cancer Cells Cancer Res., January 15, 2009; 69(2): 709 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Brown, Y. Y. Huang, J. S. Marshall, C. A. King, D. W. Hoskin, and R. Anderson Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells J. Leukoc. Biol., January 1, 2009; 85(1): 71 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Paone, D. Starace, R. Galli, F. Padula, P. De Cesaris, A. Filippini, E. Ziparo, and A. Riccioli Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-{alpha}-dependent mechanism Carcinogenesis, July 1, 2008; 29(7): 1334 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Abrahams, P. B. Aldo, S. P. Murphy, I. Visintin, K. Koga, G. Wilson, R. Romero, S. Sharma, and G. Mor TLR6 Modulates First Trimester Trophoblast Responses to Peptidoglycan J. Immunol., May 1, 2008; 180(9): 6035 - 6043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Funami, M. Sasai, Y. Ohba, H. Oshiumi, T. Seya, and M. Matsumoto Spatiotemporal Mobilization of Toll/IL-1 Receptor Domain-Containing Adaptor Molecule-1 in Response to dsRNA J. Immunol., November 15, 2007; 179(10): 6867 - 6872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Morikawa, A. Sugiyama, H. Kume, S. Ota, T. Kashima, K. Tomita, T. Kitamura, T. Kodama, M. Fukayama, and H. Aburatani Identification of Toll-Like Receptor 3 as a Potential Therapeutic Target in Clear Cell Renal Cell Carcinoma Clin. Cancer Res., October 1, 2007; 13(19): 5703 - 5709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Salaun, S. Lebecque, S. Matikainen, D. Rimoldi, and P. Romero Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy? Clin. Cancer Res., August 1, 2007; 13(15): 4565 - 4574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Jiang, C. W. Bell, and D. S. Pisetsky The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid J. Immunol., May 15, 2007; 178(10): 6495 - 6503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Akazawa, T. Ebihara, M. Okuno, Y. Okuda, M. Shingai, K. Tsujimura, T. Takahashi, M. Ikawa, M. Okabe, N. Inoue, et al. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells PNAS, January 2, 2007; 104(1): 252 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ma, J. Li, I. Chiu, Y. Wang, J. A. Sloane, J. Lu, B. Kosaras, R. L. Sidman, J. J. Volpe, and T. Vartanian Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis J. Cell Biol., October 23, 2006; 175(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
